Evidence map›Paper›PMID 38991943›Full record

ArticleJournal of gynecologic oncology2024

Detailed report on the clinicopathological factors of patients with endometrial cancer in Japan: a JSOG gynecologic tumor registry-based study.

Takeshi Makabe, Wataru Yamagami, Fumiaki Takahashi, Hideki Tokunaga, Eiko Yamamoto, Yoshihito Yokoyama, Kiyoshi Yoshino, Kei Kawana, Satoru Nagase

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of gynecologic oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Takeshi MakabeDepartment of Obstetrics and Gynecology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.ORCID 0000-0002-0443-2527
Wataru YamagamiDepartment of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan. gami@z8.keio.jp.ORCID 0000-0003-3925-6057
Fumiaki TakahashiDepartment of Information Science, Iwate Medical University, Iwate, Japan.ORCID 0000-0001-9201-1089
Hideki TokunagaDepartment of Gynecology, Tohoku University Hospital, Miyagi, Japan.ORCID 0000-0002-1622-3810
Eiko YamamotoDepartment of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0002-0517-5091
Yoshihito YokoyamaDepartment of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Aomori, Japan.ORCID 0000-0001-5214-512X
Kiyoshi YoshinoDepartment of Obstetrics and Gynecology, University of Occupational and Environmental Health, Fukuoka, Japan.ORCID 0000-0002-5732-5215
Kei KawanaDepartment of Obstetrics and Gynecology, Nihon University School of Medicine, Tokyo, Japan.ORCID 0000-0003-1919-8830
Satoru NagaseDepartment of Obstetrics and Gynecology, Yamagata University, Yamagata, Japan.ORCID 0000-0001-5212-1128

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn this study, we collected data over 8 years (2012-2019) from the Japan Society of Obstetrics and Gynecology (JSOG) tumor registry to determine the status of endometrial cancer in Japan, and analyzed detailed clinicopathological factors.

methodsThe JSOG maintains a tumor registry that gathers information on endometrial cancer treated at the JSOG-registered institutions. Data from the patients whose endometrial cancer treatment was initiated from 2012 to 2019 were analyzed retrospectively.

resultsA total of 82,969 patients with endometrial cancer underwent treatment from 2012 to 2019. Chemotherapy alone or in combination with hormonal therapy is more common among endometrial cancer patients under 40 years compared with those over 40 years. The number of patients with endometrial cancer, treated with laparoscopic or robot-assisted surgery was observed to have increased yearly. Small cell carcinomas and undifferentiated carcinomas were more likely to be diagnosed at an advanced stage. Lymphadenectomy was most commonly performed for stage IIIC2 disease, whereas positive peritoneal washing cytology was most common for stage IVB and serous carcinoma.

conclusionMulti-year summary reports provided detailed clinicopathological information regarding endometrial cancer that could not be obtained in a single year. These reports were useful in understanding treatment strategies and trends over time based on age, histology, and stage.

Indexed as

Endometrial NeoplasmsNeoplasm StagingRegistriesAdultAgedAged, 80 and overFemaleHumansJapanLaparoscopyLymph Node ExcisionMiddle AgedRetrospective StudiesRobotic Surgical ProceduresData Extraction StudyEndometrial CancerJapan

Identifiers

PMID38991943
PMCPMC11262896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.